US Capitol Capsule: Educating Scalia: NIH, Smithsonian genome exhibit aims to teach
This article was originally published in Scrip
Executive Summary
In the Supreme Court's ruling last week in Association for Molecular Pathology v Myriad Genetics, in which the high court unanimously ruled that a naturally occurring DNA segment is not patent eligible but complementary DNA, or cDNA, is patentable, Justice Antonin Scalia outed himself as lacking the scientific understanding of the "fine details of molecular biology" and was "unable to affirm those details on my own knowledge or even my own belief."